Literature DB >> 17880830

Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?

Laurence Klotz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880830     DOI: 10.1007/s11934-007-0027-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  30 in total

1.  Prostate biopsy: how many cores are enough?

Authors:  Joseph C Presti
Journal:  Urol Oncol       Date:  2003 Mar-Apr       Impact factor: 3.498

2.  Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Authors:  Richard Choo; Laurence Klotz; Cyril Danjoux; Gerard C Morton; Gerrit DeBoer; Ewa Szumacher; Neil Fleshner; Peter Bunting; George Hruby
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

3.  Deferred treatment for prostate cancer.

Authors:  R Handley; T W Carr; D Travis; P H Powell; R R Hall
Journal:  Br J Urol       Date:  1988-09

4.  Prostate cancer and the Will Rogers phenomenon.

Authors:  Peter C Albertsen; James A Hanley; George H Barrows; David F Penson; Pam D H Kowalczyk; M Melinda Sanders; Judith Fine
Journal:  J Natl Cancer Inst       Date:  2005-09-07       Impact factor: 13.506

5.  Prognosis of localised prostatic cancer managed by "watch and wait" policy.

Authors:  G Waaler; A E Stenwig
Journal:  Br J Urol       Date:  1993-08

6.  Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.

Authors:  J E Johansson; L Holmberg; S Johansson; R Bergström; H O Adami
Journal:  JAMA       Date:  1997-02-12       Impact factor: 56.272

7.  Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.

Authors:  H Gilbert Welch; Lisa M Schwartz; Steven Woloshin
Journal:  J Natl Cancer Inst       Date:  2005-08-03       Impact factor: 13.506

Review 8.  Long-term survival and mortality in prostate cancer treated with noncurative intent.

Authors:  G Aus; J Hugosson; L Norlén
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

9.  Quality of life after radical prostatectomy or watchful waiting.

Authors:  Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

Review 10.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.